Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989;27(Suppl 1):69S–72S. doi: 10.1111/j.1365-2125.1989.tb03464.x

Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients

C Liegeois-Chauvel, P Marquis, D Gisselbrecht, R Pantieri, D Beaumont, P Chauvel
PMCID: PMC1379682  PMID: 2757912

Abstract

1 Vigabatrin has proved to be a very effective antiepileptic in clinical trials, with excellent long term tolerability.

2 The purpose of this study was to test the central nervous system (CNS) safety of the drug during long term clinical use, due to the existence of species-dependent intramyelinic oedema in animal toxicology studies.

3 Somatosensory evoked potentials were recorded repeatedly over a mean period of 11 months, in 54 adult patients with refractory epilepsy who received vigabatrin as add-on therapy to their current antiepileptic regime.

4 There was no suggestion throughout the study that vigabatrin could lead to a prolongation of neuronal conduction times within the CNS pathways.

5 The results are consistent with previous studies of somatosensory, visual and brainstem auditory evoked potentials in patients. In view of the results observed in the dog, where increases in central latencies of somatosensory evoked potentials were clearly apparent, these data provide strong reassurance about the neurological safety of vigabatrin in the treatment of epileptic patients.

Keywords: vigabatrin, somatosensory evoked potentials, intramyelinic oedema, animal toxicology

Full text

PDF
69S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butler W. H., Ford G. P., Newberne J. W. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Toxicol Pathol. 1987;15(2):143–148. doi: 10.1177/019262338701500203. [DOI] [PubMed] [Google Scholar]
  2. Cosi V., Callieco R., Galimberti C. A., Manni R., Tartara A., Lanzi G., Balottin U., Perucca E. Effect of vigabatrin (gamma-vinyl-GABA) on visual, brainstem auditory and somatosensory evoked potentials in epileptic patients. Eur Neurol. 1988;28(1):42–46. doi: 10.1159/000116227. [DOI] [PubMed] [Google Scholar]
  3. Desmedt J. E., Cheron G. Somatosensory evoked potentials to finger stimulation in healthy octogenarians and in young adults: wave forms, scalp topography and transit times of parietal and frontal components. Electroencephalogr Clin Neurophysiol. 1980 Dec;50(5-6):404–425. doi: 10.1016/0013-4694(80)90007-3. [DOI] [PubMed] [Google Scholar]
  4. Hammond E. J., Wilder B. J. Effect of gamma-vinyl GABA on human pattern evoked visual potentials. Neurology. 1985 Dec;35(12):1801–1803. doi: 10.1212/wnl.35.12.1801. [DOI] [PubMed] [Google Scholar]
  5. Hammond E. J., Wilder B. J. Gamma-vinyl GABA. Gen Pharmacol. 1985;16(5):441–447. doi: 10.1016/0306-3623(85)90002-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES